248 related articles for article (PubMed ID: 25557354)
1. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.
Sandgren P; Diedrich B
Vox Sang; 2015 May; 108(4):340-9. PubMed ID: 25557354
[TBL] [Abstract][Full Text] [Related]
2. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation.
Picker SM; Speer R; Gathof BS
Transfusion; 2004 Mar; 44(3):320-9. PubMed ID: 14996187
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
[TBL] [Abstract][Full Text] [Related]
4. Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.
Ohlsson S; Diedrich B; Uhlin M; Sandgren P
Vox Sang; 2018 Oct; 113(7):611-621. PubMed ID: 30156292
[TBL] [Abstract][Full Text] [Related]
5. Cryopreservation of buffy coat-derived platelet concentrates photochemically treated with amotosalen and UVA light.
Meinke S; Wikman A; Gryfelt G; Hultenby K; Uhlin M; Höglund P; Sandgren P
Transfusion; 2018 Nov; 58(11):2657-2668. PubMed ID: 30281156
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
[TBL] [Abstract][Full Text] [Related]
7. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.
Hechler B; Ohlmann P; Chafey P; Ravanat C; Eckly A; Maurer E; Mangin P; Isola H; Cazenave JP; Gachet C
Transfusion; 2013 Jun; 53(6):1187-200. PubMed ID: 23067365
[TBL] [Abstract][Full Text] [Related]
8. Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
Bertaggia Calderara D; Crettaz D; Aliotta A; Barelli S; Tissot JD; Prudent M; Alberio L
Transfusion; 2018 Oct; 58(10):2395-2406. PubMed ID: 30229925
[TBL] [Abstract][Full Text] [Related]
9. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets.
Bashir S; Cookson P; Wiltshire M; Hawkins L; Sonoda L; Thomas S; Seltsam A; Tolksdorf F; Williamson LM; Cardigan R
Transfusion; 2013 May; 53(5):990-1000. PubMed ID: 22905813
[TBL] [Abstract][Full Text] [Related]
10. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N
Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361
[TBL] [Abstract][Full Text] [Related]
12. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.
Knutson F; Osselaer J; Pierelli L; Lozano M; Cid J; Tardivel R; Garraud O; Hervig T; Domanovic D; Cukjati M; Gudmundson S; Hjalmarsdottir IB; Castrillo A; Gonzalez R; Brihante D; Santos M; Schlenke P; Elliott A; Lin JS; Tappe D; Stassinopoulos A; Green J; Corash L
Vox Sang; 2015 Nov; 109(4):343-52. PubMed ID: 25981525
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics study of platelet concentrates photochemically treated with amotosalen and UVA light for pathogen inactivation.
Jóhannsson F; Árnason NÁ; Landrö R; Guðmundsson S; Sigurjonsson ÓE; Rolfsson Ó
Transfusion; 2020 Feb; 60(2):367-377. PubMed ID: 31802514
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.
Brouard N; Pissenem-Rudwill F; Mouriaux C; Haas D; Galvanin A; Kientz D; Mangin PH; Isola H; Hechler B
Transfusion; 2023 Oct; 63(10):1937-1950. PubMed ID: 37615493
[TBL] [Abstract][Full Text] [Related]
15. Pathogen reduction of double-dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects.
Rosskopf K; Helmberg W; Schlenke P
Transfusion; 2020 Sep; 60(9):2058-2066. PubMed ID: 32619068
[TBL] [Abstract][Full Text] [Related]
16. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.
Thiele T; Sablewski A; Iuga C; Bakchoul T; Bente A; Görg S; Völker U; Greinacher A; Steil L
Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s63-70. PubMed ID: 22890270
[TBL] [Abstract][Full Text] [Related]
17. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?
van der Meer PF; Bontekoe IJ; Daal BB; de Korte D
Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624
[TBL] [Abstract][Full Text] [Related]
18. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
Kaiser-Guignard J; Canellini G; Lion N; Abonnenc M; Osselaer JC; Tissot JD
Blood Rev; 2014 Nov; 28(6):235-41. PubMed ID: 25192602
[TBL] [Abstract][Full Text] [Related]
19. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
[TBL] [Abstract][Full Text] [Related]
20. Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.
Cid J
Vox Sang; 2017 Oct; 112(7):607-613. PubMed ID: 28833219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]